Get the Stockscreener App
30.67
0.20%
0.06
After Hours:
30.67
Claritev Corp stock is traded at $30.67, with a volume of 72,049.
It is up +0.20% in the last 24 hours and up +121.12% over the past month.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
See More
Previous Close:
$30.61
Open:
$31
24h Volume:
72,049
Relative Volume:
0.51
Market Cap:
$522.86M
Revenue:
$978.76M
Net Income/Loss:
$-286.52M
P/E Ratio:
-1.7707
EPS:
-17.3212
Net Cash Flow:
$-31.63M
1W Performance:
+8.18%
1M Performance:
+121.12%
6M Performance:
-20.03%
1Y Performance:
-23.00%
1-Day Range:
$29.90
$31.84
1-Week Range:
$27.92
$33.62
52-Week Range:
$11.50
$74.07
Claritev Corp Stock (CTEV) Company Profile
Name
Claritev Corp
Sector
Industry
Phone
212-780-2000
Address
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
30.67 | 521.83M | 978.76M | -286.52M | -31.63M | -17.32 |
VEEV
Veeva Systems Inc
|
163.38 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.14 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
50.56 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
85.66 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
67.81 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-24-26 | Initiated | Barclays | Overweight |
| Jan-12-26 | Initiated | Guggenheim | Buy |
| Jan-09-26 | Initiated | Wells Fargo | Equal Weight |
| Oct-21-25 | Upgrade | Citigroup | Neutral → Buy |
| May-29-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Neutral |
| Dec-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Jul-12-22 | Initiated | Goldman | Neutral |
| Oct-04-21 | Resumed | Citigroup | Buy |
| Apr-07-21 | Initiated | B. Riley Securities | Buy |
| Mar-19-21 | Initiated | Barclays | Equal Weight |
View All
Claritev Corp Stock (CTEV) Latest News
The No Surprises Act at a Crossroads: From Protection to Performance - marketscreener.com
Is Claritev Corp (CTEV) a Bargain After 3.6% Drop? GF Value Says Undervalued - GuruFocus
How The Claritev (CTEV) Investment Story Is Evolving As The Market Holds Its Fair Value View - Yahoo Finance
Insider Buying: Nutter Carol Acquires Shares of Claritev Corp (C - GuruFocus
Claritev SVP Carol Nutter buys $24,856 in company stock By Investing.com - Investing.com Nigeria
Claritev SVP Carol Nutter buys $24,856 in company stock - Investing.com
Claritev (CTEV) chief people officer buys 875 company shares - Stock Titan
Claritev (CTEV) Q1 2026 Earnings Transcript - AOL.com
Piper Sandler Maintains Claritev(CTEV.US) With Buy Rating, Cuts Target Price to $61 - Moomoo
Claritev Cares and Elizabeth Dole Foundation Team Up to Help Military and Veteran Caregivers Navigate Mental Health Benefits - 01net
New free guides help military caregivers untangle mental health insurance - Stock Titan
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Claritev Corp - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Claritev Corporation (CTEV) And Encourages Shareholders to Connect - ACCESS Newswire
Claritev faces DOJ price-fixing probe, shares plunge 41% amid investigation. - Pluang
Arizona sues MultiPlan, major insurers, alleging a 'cartel' that underpaid doctors and hospitals - Arizona Mirror
Claritev Q1 2026 Earnings Call Transcript - Benzinga
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-05-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation | NYSE:CTEV | Press Release - Stockhouse
Claritev (CTEV) Receives Buy Rating and $32 Target from Canaccor - GuruFocus
CTEV Initiated Coverage by Canaccord Genuity -- Rating Set to Bu - GuruFocus
Claritev Corporation (CTEV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Claritev Corporation (CTEV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Canaccord Genuity Initiates Claritev at Buy With $32 Price Target - marketscreener.com
CCORF Initiates Claritev(CTEV.US) With Buy Rating, Announces Target Price $32 - Moomoo
Claritev Corporation (CTEV) Investigation: Bronstein, Gewirtz & G - The National Law Review
CTEV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Claritev Corporation - Business Wire
CTEV Q1 2026 Earnings: EPS Misses Estimates Amid Operational Challenges; Stock RalliesEarnings Beat Streak - thelegaladvocate.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Claritev Corporation (CTEV) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Claritev Corporation (CTEV) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Claritev Corporatio - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Claritev jumps after responding to claims about DOJ investigation - MSN
A Look at Claritev Corp (CTEV) After 8.0% Decline -- GF Value $3 - GuruFocus
Claritev faces civil conduct probe - Global Competition Review
Claritev Q1 Earnings Call Highlights - MSN
Securities Fraud Investigation Into Claritev Corporation (CTEV) C - The National Law Review
Lobbying Update: $40,000 of CLARITEV (FKA MULTIPLAN CORPORATION) lobbying was just disclosed - Quiver Quantitative
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Claritev Corporation (CTEV) And Encourages Stockholders to Reach Out - ACCESS Newswire
Claritev faces DOJ price-fixing probe; shares plunge nearly 50%. - Pluang
Claritev shares plunge 41% amid DOJ criminal price-fixing probe on its pricing tool. - Pluang
Bronstein, Gewirtz & Grossman, LLC Is Investigating Claritev Corporation (CTEV) And Encourages Stockholders to Connect - ACCESS Newswire
CTEV SHAREHOLDER ALERT: Investors Encouraged to Contact - GlobeNewswire
Claritev faces DOJ price-fixing probe; shares plunge 41% triggering investor lawsuit inquiry - Pluang
Claritev targets $80M-$100M ACV bookings in 2026 while raising revenue outlook to $985M-$1B - MSN
Claritev Earnings Call Signals AI-Fueled Growth Path - TipRanks
Claritev Corporation (CTEV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Claritev (CTEV) Receives a Buy from Barclays - The Globe and Mail
Insider Buying: John Prince Acquires 10,000 Shares of Claritev C - GuruFocus
Claritev Insiders Go on a Buying Spree as Top Brass Double Down on the Future - TipRanks
Claritev Corp Stock (CTEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.22%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):